Long-Term, Open-Label, Flexible-Dose, Extension Study Of Vortioxetine In Child And Adolescent Patients With Major Depressive Disorder (Mdd)
Posted Date: Jan 14, 2020
- Investigator: Melissa Delbello
- Specialties: Adolescent Psychiatry/Psychology, Depression, Psychiatry/Psychology
- Type of Study: Drug
The goal of this study is to evaluate the long-term safety and efficacy of an investigational medication in children with depression. This study is open-label, which means that all participants will receive the medication (vortioxetine) for up to 6 months.
Criteria:
Children Who Completed The 12 Week Lead In Study. (12709A Roll-Over Participant)
Keywords:
Major Depressive Disorder, Depression, Children
For More Information:
Kaitlyn Bruns
(513) 558-5303
brunskn@ucmail.uc.edu